169 related articles for article (PubMed ID: 10555222)
1. [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Grosclaude P
Prog Urol; 1999 Sep; 9(4):689-95. PubMed ID: 10555222
[TBL] [Abstract][Full Text] [Related]
2. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
[TBL] [Abstract][Full Text] [Related]
3. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
4. Post orchiectomy management in stage II testicular seminoma.
Singhal S; Dixit S; Murthy RR; Neema JP; Vyas RK; Baboo HA
Indian J Cancer; 1994 Dec; 31(4):226-34. PubMed ID: 7533129
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancer in irradiated stage I testicular seminoma.
Stein ME; Steiner M; Lachter J; Kessel I; Moskovitz B; Kuten A
Strahlenther Onkol; 1993 Nov; 169(11):672-7. PubMed ID: 8248844
[TBL] [Abstract][Full Text] [Related]
6. Secondary malignancy among seminoma patients treated with adjuvant radiation therapy.
Chao CK; Lai PP; Michalski JM; Perez CA
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):831-5. PubMed ID: 7591890
[TBL] [Abstract][Full Text] [Related]
7. Mortality after cure of testicular seminoma.
Zagars GK; Ballo MT; Lee AK; Strom SS
J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
[TBL] [Abstract][Full Text] [Related]
8. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
9. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
[TBL] [Abstract][Full Text] [Related]
10. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
11. Management of Stage II testicular seminoma over a period of 40 years.
Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
[TBL] [Abstract][Full Text] [Related]
13. [Treatment-related complications after radiotherapy for testicular malignancies--seminoma stage I and II].
Golubicić I; Jelić-Radosević Lj; Sobić V
Srp Arh Celok Lek; 1994; 122(1-2):24-6. PubMed ID: 17972797
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
[TBL] [Abstract][Full Text] [Related]
15. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
16. The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
Cancer; 2000 Jun; 88(11):2629-35. PubMed ID: 10861442
[TBL] [Abstract][Full Text] [Related]
17. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
18. [The clinical treatment analysis of 176 cases of testicular germ cell tumor].
Zhang P; Zeng H; Lu YP; Yuan Y; Li H
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):237-9. PubMed ID: 16597041
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of multimodality therapy of testicular germ cell tumor].
Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
[TBL] [Abstract][Full Text] [Related]
20. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]